Esperion Therapeutics Inc

FDA Filings

This page includes the latest FDA filings for Esperion Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

USANASDAQESPRDUNS 029516312
FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
Esperion Therapeutics, Inc.
Prescription Medication2024-06-08
Esperion Therapeutics, Inc.
Prescription Medication2024-04-03
Esperion Therapeutics, Inc.
Prescription Medication2024-04-03
Esperion Therapeutics, Inc.
Prescription Medication2023-12-16
Esperion Therapeutics, Inc.
Prescription Medication2023-12-16
Esperion Therapeutics, Inc.
Prescription Medication2023-09-28
Esperion Therapeutics, Inc.
Prescription Medication2023-09-28
Esperion Therapeutics, Inc.
Prescription Medication2023-09-13
Esperion Therapeutics, Inc.
Prescription Medication2023-09-08
Esperion Therapeutics, Inc.
Prescription Medication2023-06-28
Esperion Therapeutics, Inc.
Prescription Medication2023-06-28
Esperion Therapeutics, Inc.
Prescription Medication2022-10-12
Esperion Therapeutics, Inc.
Prescription Medication2022-10-09
Esperion Therapeutics, Inc.
Prescription Medication2021-10-02
Esperion Therapeutics, Inc.
Prescription Medication2021-10-02
Esperion Therapeutics, Inc.
Prescription Medication2020-11-13
Esperion Therapeutics, Inc.
Prescription Medication2020-11-06
Esperion Therapeutics, Inc.
Prescription Medication2020-03-14
Esperion Therapeutics, Inc.
Prescription Medication2020-03-11
Esperion Therapeutics, Inc.
Nexlizet2020-03-09
Esperion Therapeutics, Inc.
Nexletol2020-03-06
Esperion Therapeutics, Inc.
Prescription Medication2020-03-06

Similar & Related FDA Registered Companies

    Related Finance Registrations

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.